Key result
Anthracycline chemotherapy acutely prolongs QTc by ~28 ms and impairs mechanical strain through 3 months.
Why the study?
The acute cardiotoxic effects of anthracycline chemotherapy on echocardiographic strain and electrocardiographic repolarization parameters in breast cancer patients were not well described.
Does anthracycline chemotherapy induce early changes in echocardiographic strain and electrocardiographic repolarization parameters in patients with breast cancer?
Cohort (n=35)
Does anthracycline chemotherapy induce early changes in echocardiographic strain and electrocardiographic repolarization parameters in patients with breast cancer?
Anthracycline chemotherapy induces acute and sustained (up to 3 months) impairments in electrical repolarization and mechanical strain parameters (circumferential, radial, and torsion) in breast cancer patients, preceding changes in global longitudinal strain.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for early anthracycline cardiotoxicity monitoring; should not yet change practice or guide therapy.
OBJECTIVE: The aim of the study was to describe the acute cardiotoxic effects of anthracycline chemotherapy in echocardiographic strain and electrocardiographic repolarization parameters in patients with breast cancer. METHODS: A total of 35 consecutive patients (all females, mean age: 48.9 ± 11.8 years) who received chemotherapy due to breast cancer were prospectively included. Pre-treatment (T0) and third month (T2) 2-dimensional strain echocardiography and electrocardiography were performed. Additionally, within 3 hours of the first dose of chemotherapy (T1), additional electrocardiographic images were obtained. All mechanical and electrical parameters from different time intervals (T0, T1, and T2) were compared with each other. RESULTS: In the acute period after treatment, electrocardiographic repolarization parameters were prolonged and this prolongation continued to the third month (QT corrected with Bazett formula [440.10 ± 27.63 (T0), 468.00 ± 38.98 (T1), 467.86 ± 35.09 (T2)], QT dispersion [49.85 ± 19.52 (T0), 69.54 ± 16.06 (T1), 57.63 ± 14.42 (T2)], and T-wave peak-to-end interval [94.00 ± 45.46 (T0), 131.20 ± 17.79 (T1), 120.00 ± 18.32 (T2)]; P < .001). There was no significant change in global longitudinal strain values before and after treatment (global longitudinal strain avg: -21 ± 7.1%; P = .8). However, there were significant reductions in strain parameters including circumferential and radial strain, and torsion (-17.2 ± 3.5 to -13 ± 2.84; P < .001, 45.1 ± 8.3 to 35.6 ± 10; P <.001, and 12.1 ± 3.5 to 7.7 ± 2.1; P < .001, respectively). CONCLUSION: Both the electrical and mechanical functions of the heart can be impaired acutely extending to 3 months after anthracycline chemotherapy. Therefore, cardiotoxicity should be evaluated early both electrically and mechanically after chemotherapy.
No takes yet. Share an insight, caveat, or question.
Özbay et al. (2022) conducted a cohort in Breast cancer (n=35). Anthracycline chemotherapy vs. Pre-treatment baseline was evaluated on Electrocardiographic repolarization and echocardiographic strain parameters (p=<.001). Anthracycline chemotherapy acutely impaired electrical repolarization and mechanical strain parameters, with effects persisting at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: